SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001562762-17-000128
Filing Date
2017-08-09
Accepted
2017-08-09 16:16:17
Documents
59
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q scln-20170630x10q.htm 10-Q 1541731
2 EX-31.1 scln-20170630xex31_1.htm EX-31.1 18215
3 EX-31.2 scln-20170630xex31_2.htm EX-31.2 18310
4 EX-32.1 scln-20170630xex32_1.htm EX-32.1 12577
5 EX-32.2 scln-20170630xex32_2.htm EX-32.2 15349
  Complete submission text file 0001562762-17-000128.txt   5308293

Data Files

Seq Description Document Type Size
6 EX-101.INS scln-20170630.xml EX-101.INS 1152516
7 EX-101.SCH scln-20170630.xsd EX-101.SCH 35370
8 EX-101.CAL scln-20170630_cal.xml EX-101.CAL 41640
9 EX-101.DEF scln-20170630_def.xml EX-101.DEF 85608
10 EX-101.LAB scln-20170630_lab.xml EX-101.LAB 249460
11 EX-101.PRE scln-20170630_pre.xml EX-101.PRE 207700
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Filer) CIK: 0000880771 (see all company filings)

IRS No.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19825 | Film No.: 171018070
SIC: 2834 Pharmaceutical Preparations